Sign In
Share

PreHevbrio (PreHevbrio)

Other Names: Sci-B-VacTM

All Clinical Trials

PROTECT: PreHevbrio versus Engerix-B in Healthy Adults Industry
Official Title A Phase 3 Double-Blind Randomized Controlled Trial to Compare the Immunogenicity and Safety of a Three-dose Regimen of Sci-B-Vac® to a Three-dose Regimen of Engerix-B® in Adults (PROTECT)
ClinicalTrials.gov NCT03393754
Treatments
PreHevbrio

PreHevbrio

Tradename:PreHevbrioOther Names:Sci-B-VacTMClass:Vaccines (HBV)
Funding
IndustryVBI Vaccines
References
  • Vesikari T, Langley JM, Segall N, et al. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2021;21:1271-81.
    [PubMed Abstract]
CONSTANT: PreHevbrio Vaccine vs Engerix-B Vaccine in Healthy Adults Age 18-45 years Industry
Official Title A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)
Phase Phase III
ClinicalTrials.gov NCT03408730
Treatments
PreHevbrio

PreHevbrio

Tradename:PreHevbrioOther Names:Sci-B-VacTMClass:Vaccines (HBV)
Funding
IndustryVBI Vaccines
References
  • Vesikari T, Finn A, van Damme P, et al. Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial. JAMA Netw Open. 2021;4:e2128652.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.